Intraocular sustained release drug delivery systems and methods for treating ocular conditions

摘要

#$%^&*AU2018211329A120180823.pdf#####I: mdtInterwo nNRPortblDCCMDTI 1455033_.docx-22 09/2016 INTRAOCULAR SUSTAINED RELEASE DRUG DELIVERY SYSTEMS AND METHODS FOR TREATING OCULAR CONDITIONS Abstract Biocompatible, bioerodible sustained release implants and microspheres for intracameral or anterior vitreal placement include an anti-hypertensive agent and a biodegradable polymer effective to treat an ocular hypertensive condition (such as glaucoma) by relapsing therapeutic amount of the anti-hypertensive agent over a period of time between 10 days and 1 year.